RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 106 filers reported holding RAPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $452,596 | -1.9% | 27,232 | +10.4% | 0.00% | 0.0% |
| Q2 2023 | $461,441 | -22.1% | 24,676 | -23.6% | 0.00% | -50.0% |
| Q1 2023 | $592,540 | +4.0% | 32,291 | +12.2% | 0.00% | 0.0% |
| Q4 2022 | $569,725 | -2.3% | 28,774 | +18.8% | 0.00% | 0.0% |
| Q3 2022 | $583,000 | +47.2% | 24,222 | +11.6% | 0.00% | +100.0% |
| Q2 2022 | $396,000 | -36.8% | 21,701 | -23.9% | 0.00% | 0.0% |
| Q1 2022 | $627,000 | -30.3% | 28,500 | +16.3% | 0.00% | -50.0% |
| Q4 2021 | $900,000 | +18.3% | 24,500 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $761,000 | +51.6% | 24,500 | +55.1% | 0.00% | +100.0% |
| Q2 2021 | $502,000 | +43.0% | 15,800 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $351,000 | +12.5% | 15,800 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $312,000 | -45.5% | 15,800 | -11.2% | 0.00% | 0.0% |
| Q3 2020 | $573,000 | – | 17,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $49,189,395 | 17.79% |
| Euclidean Capital LLC | 432,900 | $7,943,715 | 6.97% |
| GREAT POINT PARTNERS LLC | 1,355,151 | $24,867,021 | 4.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 875,984 | $16,074,306 | 3.02% |
| Trustees of Columbia University in the City of New York | 80,580 | $1,478,643 | 2.64% |
| Perceptive Advisors | 2,291,608 | $42,051,007 | 1.24% |
| Cormorant Asset Management, LP | 650,000 | $11,928 | 0.79% |
| Alphabet Inc. | 540,270 | $9,913,955 | 0.55% |
| Redmile Group, LLC | 688,132 | $12,627,222 | 0.55% |
| Orbimed Advisors | 1,251,070 | $22,957,135 | 0.45% |